Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2024
Alternative splicing of <i>Clock</i> transcript mediates the response of circadian clocks to temperature changes
Yao D Cai, Xianhui Liu, Gary K Chow, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
July 26, 2011
Pharmacokinetics of hydralazine, an antihypertensive and DNA-demethylating agent, using controlled-release formulations designed for use in dosing schedules based on the acetylator phenotype
A Gonzalez-Fierro, D Vasquez-Bahena, L Taja-Chayeb, et al.
Experimental Eye Research
|
October 27, 2018
A novel role for CRIM1 in the corneal response to UV and pterygium development
Eleonora Maurizi, Davide Schiroli, Sarah D Atkinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
E Izumchenko, K Paz, D Ciznadija, et al.
Blood
|
February 4, 2026
A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT
Muhammad Umair Mushtaq, John F DiPersio, Jacques Azzi, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2024
Alternative splicing of <i>Clock</i> transcript mediates the response of circadian clocks to temperature changes
Yao D Cai, Xianhui Liu, Gary K Chow, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
July 26, 2011
Pharmacokinetics of hydralazine, an antihypertensive and DNA-demethylating agent, using controlled-release formulations designed for use in dosing schedules based on the acetylator phenotype
A Gonzalez-Fierro, D Vasquez-Bahena, L Taja-Chayeb, et al.
Experimental Eye Research
|
October 27, 2018
A novel role for CRIM1 in the corneal response to UV and pterygium development
Eleonora Maurizi, Davide Schiroli, Sarah D Atkinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
E Izumchenko, K Paz, D Ciznadija, et al.
Blood
|
February 4, 2026
A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT
Muhammad Umair Mushtaq, John F DiPersio, Jacques Azzi, et al.
Page
of 6